In these new roles, Dr. Garcia will serve as the director of the new center for the study of inflammation biology and promote ways to enhance research. Recently, Dr. Garcia has served as founder and CEO of Aqualung Therapeutics and taught at Tucson-based University of Arizona.
Dr. Garcia is a pulmonologist specializing in the genetic basis of inflammatory lung disease, according to a Nov. 8 UF Health news release.
“Dr. Garcia joins us at a pivotal moment in our history as the Southeast’s premier academic health center, and his work will help accelerate our ability to move discoveries into clinical advances that translate into improved outcomes for patients, both in Florida and around the world,” David Nelson, MD, senior vice president for health affairs at UF and president of UF Health, said.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.